Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 15, 2021 | EyeYon | $25.0M Series C | CR-CP Life Science Fund | Brighton Park Capital, Diamond BioFund, Pontifax, Rimonci Capital, Triventures |
| Feb 1, 2020 | Volastra Therapeutics | $12.0M Seed | Amy Schulman | NanoDimension, Polaris Partners, ARCH Venture Partners, Luc Dochez, Zafrira Avnur |
| Jan 1, 2020 | Eyevensys | $30.0M Series B | Boehringer Ingelheim | Pureos Bioventures, Bpifrance, Neena Kadaba, Inserm Transfert, Karista, Pontifax, Dominik Escher, Quark Venture |
| Jan 1, 2019 | Keros Therapeutics | $23.0M Series B | — | Pontifax Venture Capital, Arkin Bio Ventures, Medison Pharma, Partners Innovation Fund |
| Aug 1, 2018 | SQZ Biotech | $72.0M Series C | — | 8VC, ARCH Venture Partners, Flagship Ventures, NanoDimension, Polaris Partners, Marc Elia, Everblue, Zafrira Avnur, Google Ventures, Illumina Ventures, Invus, JDRF, NanoDimension, Orient Life, Amy Schulman, Viva Ventures Biotech Group |